Close close-icon
notification-icon

Important Alerts:

COVID-19 Information and Updates
For the latest news about the COVID-19 vaccine, eligibility, testing and more click  here.
Expect up to 3 days for results of the routine RNA Nasal Swab Test. Rapid testing is NOT routinely available. For more information, click here.

For other alerts, click here.

Close

I am extremely excited to be a part of the CareMount team as a Gastroenterologist and Hepatologist. I grew up in Queens, NY and have lived in and around New Haven, CT for the past 7 years as I completed my medical training. I take great pride in using empathy as a powerful tool for getting to know and treat my patients. It is important for me to take the time to get to know each individual so that I can truly appreciate how their medical illness prevents them from living the life they desire, and to tailor my workup and treatment plans accordingly. I hope to utilize the knowledge that I have learned from taking care of extremely complex patients at Yale-New Haven Hospital to provide the highest quality care to my patients at CareMount. My special interests within the field of Gastroenterology and Hepatology include Colon Cancer screening and prevention, Irritable Bowel Syndrome, Gut Microbiome Dysbiosis, Clostridium difficile treatment, Esophageal and swallowing disorders, Liver disease, Inflammatory Bowel Disease and Endoscopic Procedures.

I wanted to inform you of a new, promising procedure that I am presently performing – Fecal Microbiota Transplantation (FMT) for Clostridium difficile infection (CDI) when antibiotic treatment is failing. Essentially, FMT is a procedure in which fecal matter, or stool, is collected from a tested donor, mixed with saline or other solution, strained, and placed in a patient, by colonoscopy, sigmoidoscopy, or enema. Still termed as an investigational new therapy by the FDA, very few physicians are trained to perform this procedure and so I am pleased to say we are one of a few medical groups in the country that can make this available to our patients.

Locations

Fishkill Westage Campus
600 Westage Business Center Drive
Fishkill, NY 12524-2281

845-231-5600

Kingston Campus
1561 Ulster Avenue
Lake Katrine, NY 12449-5410

845-231-5600

Video

Awards & Recognition

Magna Cum Laude - Fordham University: 2006
Phi Beta Kappa - Fordham University: 2006
Fordham Club Honor Society - Fordham University: 2006
Gold Humanism Honor Society - Yale New Haven Hospital: 2013
Chief Medical Resident - Yale New Haven Hospital: 2014
Dutchess County Regional Chamber of Commerce Forty Under 40 Mover & Shaker Award: 2019

Training

Undergraduate & Graduate

Fordham University: 2006

Medical Education

Stony Brook University: 2010

Residency

Yale-New Haven Hospital: 2013
Yale-New Haven Hospital, Chief Resident: 2014

Fellowship

Yale School of Medicine: 2017

Board Certifications

American Board of Internal Medicine: 2013
American Board of Gastroenterology: 2017

Affiliations

Hospital Affiliations

Vassar Brothers Medical Center
Mid Hudson Regional Hospital of Westchester Medical Center

Languages

Hindi, Urdu, and Punjabi

Publications

Kumar, V., Grant, T., Nagar, A. (2013) Adherence to Quality of Care Measures in Patients with Inflammatory Bowel Disease May Not Improve Patient Outcomes. Digestive Disease Week. Orlando, FL 2013

Kumar, V. (2013). Acute Diarrhea. In Yale Office-based Medicine Curriculum, eds. Julie R Rosenbaum, Seonaid Hay, Laura Whitman, and Mary Warner, 8th edition. New Haven, CT: Yale University

Kumar, V., Chaptini, L., (2013). Acute Lower G.I. Bleed. In Yale Inpatient Medicine Curriculum, editor Dana Dunne. New Haven, CT: Yale University

Mansoor S., Kumar, V., Aslanian, H., (2015). Stercoral Colitis. American Journal of Gastroenterology. Image of the month. Dec;110(12):1651

Mansoor MS., Kumar V., Feuerstadt, P. Men with CDI Have Increased Co-Morbidities and Worsened Long-Term Outcome Compared with Women. Digestive Disease Week, San Diego, CA 2016

Zhou, E., Kumar, V., Mansoor, MS., Feuerstadt, P. Pseudomembranes Are Infrequently Seen in Patients Undergoing Fecal Microbiota Transplant (FMT) for Recurrent C. difficile Infection (CDI) . ACG, Las Vegas 2016

Kumar, V., Zhou, E., Mansoor, MS., Feuerstadt, P. Treatment of Initial Recurrence of C. Difficile Infection (CDI) with Vancomycin May Not Prevent Eventual Need for Fecal Microbial Transplantation (FMT). ACG, Las Vegas 2016

Afinogenova, Y., Kumar, V., Mansoor, MS., Feuerstadt, P. 5-Aminosalicylic Acid (5-ASA) Usage During C. Difficile Infection (CDI) is Associated with Decreased ICU Admission and Improved Long-Term Outcomes. ACG, Las Vegas 2016

Viera, S., Kumar, V., Kriegel, M. A Gut Commensal Breaches Both Gut Lymphatic and Vascular Barriers to Drive Systemic Autoimmunity. Keystone Symposia: Microbiome in Health and Disease. Colorado, 2017

Viera, S., Kumar, V., Kriegel, M. “Spontaneous Translocation of a Gut Pathobiont Drives Autoimmunity that is Preventable by Vaccination” - submitted, pending review. Science

Kumar V, Zhou E, Afinogenova Y, Mansoor S, Sharma P and Feuerstadt P. Serum Derived Bovine Immunoglobulin (SBI) is Safe and Well Tolerated in Patients Undergoing Fecal Microbiota Transplant (FMT) for Recurrent C. difficile Infection (RCDI). ACG, Orlando 2017

Zhou E, Kumar V, Afinogenova Y, Mansoor S, Sharma P and Feuerstadt P. Serum Derived Bovine Immunoglobulin (EnteraGam®, SBI) is Safe and Well Tolerated in Patients Undergoing Fecal Microbiota Transplant (FMT) for Recurrent C. difficile Infection (RCDI). ACG, Orlando 2017

Sharma P, Kumar V, Mansoor S, Feuerstadt P. Recurrence of C. difficile Infection (CDI) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis Treated With Metronidazole, Vancomycin or Combination Therapy. ACG, Orlando 201

Comments